https://seekingalpha.com/article/4692983-mtum-outperformance-under-rare-conditions?source=feed_tag_etf_portfolio_strategy
May 14, 2024 - MTUM tracks the performance of high momentum companies and uses a set of rules to determine momentum values. Read why MTUM ETF is a Hold.
0
sa:2541832963090174377
0
https://www.wired.com/story/time-is-running-out-hunt-for-rare-bitcoin/
May 13, 2024 - A small band of collectors is finding and collecting rare fragments of bitcoin worth many times the face value. But their window of opportunity is closing.
0
wr:-4015888722875362621
0
https://www.wired.com/story/geomagnetic-storm-aurora-night-sky/
May 10, 2024 - Three bursts of charged particles ejected from the sun have merged into a wave that could lead to brilliant auroras being visible from Moscow to Oklahoma City.
0
wr:1493914870998030018
0
https://www.cnbc.com/2024/05/09/spains-bbva-launches-rare-hostile-takeover-bid-for-rival-sabadell.html
May 09, 2024 - Spanish bank BBVA caught markets by surprise after it announced a rare hostile takeover bid for domestic rival Banco Sabadell.
0
cnbc:-6141841286440497758
0
https://seekingalpha.com/article/4689798-rare-stock-picks-in-april-2024-from-28-discerning-analysts?source=feed
May 07, 2024 -
0
sa:-9150646207800277440
0
https://www.zacks.com/stock/news/2267565/ultragenyx-rare-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2267565
May 02, 2024 - While the top- and bottom-line numbers for Ultragenyx (RARE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:7753933266242030443
0
https://seekingalpha.com/news/4096206-harmony-biosciences-acquires-epygenix-gaining-rare-epilepsy-pipeline?source=feed_sector_healthcare
Apr 30, 2024 - Harmony Biosciences acquires Epygenix Therapeutics for $35M upfront, focusing on developing treatments for rare epilepsy conditions. Read more here.
0
sa:-5379247384512780565
0
https://www.cnbc.com/2024/04/26/fda-approves-pfizer-gene-therapy-beqvez-for-treatment-of-hemophilia-b.html
Apr 26, 2024 - The agency greenlighted the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
0
cnbc:1476932458123368286
0
https://www.wired.com/story/nintendo-switch-oled-deal-april-2024/
Apr 25, 2024 - Nintendo's top-of-the-line handheld gaming console hardly ever goes on sale, making this small discount super appealing.
0
wr:-8200678755864774433
0